La radiologia medica

, Volume 123, Issue 10, pp 727–734 | Cite as

MRI features after prostatic artery embolization for the treatment of medium- and large-volume benign hyperplasia

  • Hongtao Zhang
  • Yanguang Shen
  • Jingjing Pan
  • Haiyi Wang
  • Yan Zhong
  • Yingwei Wang
  • Huiyi YeEmail author



To assess magnetic resonance imaging (MRI) features after prostatic artery embolization (PAE) for the treatment of medium- and large-volume benign prostatic hyperplasia and to correlate prostate volume with clinical indexes.


We retrospectively evaluated 28 patients who underwent PAE. MRI examinations of the prostate were performed to evaluate signal intensity changes and the characteristics of infarcted areas. Prostate volume and the apparent diffusion coefficient (ADC) were measured at an average of 10 days post-PAE and at 1, 3, 6, and 12 months post-PAE. Some clinical indexes were evaluated before and 12 months after PAE. The paired t test, ANOVA, and multiple linear correlation analyses were performed by using the statistical software, SPSS.


All patients experienced prostatic infarction. The prostate volume decreased continuously (p < 0.05). The ADC values before and after 1, 3, 6, or 12 months of embolization (b = 1000 and 2000 s/mm2) were statistically significantly different. The ADC values (b = 3000 s/mm2) were also statistically significantly different before and at each interval time after embolization (p < 0.05). Prostate volume changes correlated significantly with patient age and post-void residual urine volume (p < 0.05).


MRI can be used for assessing changes in signal intensity and ADC values of infarction as well as the volume of the prostate after PAE. After PAE, ultrahigh b value diffusion-weighted imaging (DWI) can show early infarction better than lower b value DWI.


Magnetic resonance imaging Prostatic hyperplasia Embolization Therapeutic Diffusion magnetic resonance imaging Infarction 



This study has received funding by the Health Care Special Project (14BJZ02) and National Natural Science Foundation of China (No. 81771785).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This article does not contain any studies with human participants performed by any of the authors. Each author has participated sufficiently in any submission to take public responsibility for its content. All procedures were performed in accordance with ethical standards of the Declaration of Helsinki. The study was approved by the hospital ethical committee. Written informed consent was obtained from each patient.


  1. 1.
    Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic disease in America project: benign prostatic hyperplasia. J Urol 173:1256–1261CrossRefGoogle Scholar
  2. 2.
    McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 85:1793–1803CrossRefGoogle Scholar
  3. 3.
    Kirby M, Chapple C, Jackson G, Eardley I, Edwards D, Hackett G et al (2013) Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract 67:606–618CrossRefGoogle Scholar
  4. 4.
    Geavlete B, Stanescu F, Iacoboaie C, Geavlete P (2013) Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases-a medium term, prospective, randomized comparison. BJU Int 111:793–803CrossRefGoogle Scholar
  5. 5.
    Bagla S, Martin CP, van Breda A, Sheridan MJ, Sterling KM, Papadouris D et al (2014) Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol 25:47–52CrossRefGoogle Scholar
  6. 6.
    Rampoldi A, Barbosa F, Secco S, Migliorisi C, Galfano A, Prestini G et al (2017) Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates. Cardiovasc Intervent Radiol 40:530–536CrossRefGoogle Scholar
  7. 7.
    Schnall MD, Pollack HM (1990) Magnetic resonance imaging of the prostate gland. Urol Radiol 12:109–114CrossRefGoogle Scholar
  8. 8.
    Pisco J, Campos Pinheiro L, Bilhim T, Duarte M, Rio Tinto H, Fernandes L et al (2013) Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate term results. Radiology 266:668–677CrossRefGoogle Scholar
  9. 9.
    Sosna J, Rofsky NM, Gaston SM, DeWolf WC, Lenkinski RE (2003) Determinations of prostate volume at 3-tesla using an external phased array coil. Acad Radiol 10:846–853CrossRefGoogle Scholar
  10. 10.
    Grossfeld GD, Coakley FV (2000) Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. Radiol Clin N Am 38:31–47CrossRefGoogle Scholar
  11. 11.
    Sun F, Sanchez FM, Crisostomo V, Lima JR, Luis L, García-Martínez V et al (2008) Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment—preliminary study in pigs. Radiology 246:783–789CrossRefGoogle Scholar
  12. 12.
    Little MW, Boardman P, Macdonald AC, Taylor N, Macpherson R, Crew J et al (2017) Adenomatous-dominant benign prostatic hyperplasia (AdBPH) as a predictor for clinical success following prostate artery embolization: an age-matched case-control study. Cardiovasc Intervent Radiol 40:682–689CrossRefGoogle Scholar
  13. 13.
    Wang MQ, Duan F, Yuan K, Zhang GD, Yan J, Wang Y (2017) Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy. Radiology 282:271–280CrossRefGoogle Scholar
  14. 14.
    Camara-Lopes G, Mattedi R, Antunes AA, Carnevale FC, Cerri GG, Srougi M et al (2013) The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia. Int Braz J Urol 39:222–227CrossRefGoogle Scholar
  15. 15.
    Verma SK, Gonsalves CF, Baltarowich OH, Mitchell DG, Lev-Toaff AS, Bergin D (2010) Spectrum of imaging findings on MRI and CT after uterine artery embolization. Abdom Imaging 35:118–128CrossRefGoogle Scholar
  16. 16.
    Kwon JK, Han JH, Choi HC, Kang DH, Lee JY, Kim JH et al (2016) Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia. BJU Int 117:316–322CrossRefGoogle Scholar
  17. 17.
    Isaacson AJ, Burke LM (2016) Utility of pelvic computed tomography angiography prior to prostatic artery embolization. Semin Intervent Radiol 33:224–230CrossRefGoogle Scholar
  18. 18.
    Kershaw LE, Hutchinson CE, Buckley DL (2009) Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI. J Magn Reson Imaging 29:641–648CrossRefGoogle Scholar
  19. 19.
    Slojewski M, Czerwinski F, Sikorski A (2002) Microangiographic imaging of the prostate. BJU Int 89:776–778CrossRefGoogle Scholar
  20. 20.
    Yu SCH, Cho C, Hung E, Wang D, Chiu P, Yee CH et al (2017) Case-control study of intra-arterial verapamil for intraprostatic anastomoses to extraprostatic arteries in prostatic artery embolization for benign prostatic hypertrophy. J Vasc Interv Radiol 28:1167–1176CrossRefGoogle Scholar
  21. 21.
    Shi C, Zhang D, Xiao Z, Wang L, Ma R, Chen H et al (2017) Ultrahigh b-values MRI in normal human prostate: initial research on reproducibility and age-related differences. J Magn Reson Imaging 46:801–812CrossRefGoogle Scholar
  22. 22.
    Hausmann D, Aksöz N, von Hardenberg J, Martini T, Westhoff N, Buettner S et al (2018) Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer? Eur Radiol 28:869–876CrossRefGoogle Scholar
  23. 23.
    Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2018) Head-To-head comparison between high-and standard-b-value DWI for detecting prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 210:91–100CrossRefGoogle Scholar
  24. 24.
    Park SY, Oh YT, Jung DC, Cho NH, Choi YD, Rha KH et al (2017) Diffusion-weighted imaging (DWI) predicts upgrading of Gleason score in biopsy-proven low-grade prostate cancers. BJU Int 119:57–66CrossRefGoogle Scholar
  25. 25.
    Brook OR, Faintuch S, Brook A, Goldberg SN, Rofsky NM, Lenkinski RE (2013) Embolization therapy for benign prostatic hyperplasia: influence of embolization particle size on gland perfusion. J Magn Reson Imaging 38:380–387CrossRefGoogle Scholar
  26. 26.
    Pisco JM, Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L et al (2013) Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol 23:2561–2572CrossRefGoogle Scholar
  27. 27.
    Crisostomo Ayala V, Maynar Moliner M, Sun F (2009) Ultrasonographic histological study on the evolution of a canine model of hormone-induced benign prostatic hyperplasia. Actas Urol Esp 33:895–901CrossRefGoogle Scholar
  28. 28.
    Frenk NE, Baroni RH, Carnevale FC, Gonçalves OM, Antunes AA, Srougi M et al (2014) MRI findings after prostatic artery embolization for treatment of benign hyperplasia. AJR Am J Roentgenol 203:813–821CrossRefGoogle Scholar
  29. 29.
    Gonçalves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M (2016) Comparative study using 100–300 versus 300–500 μm microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol 39:1372–1378CrossRefGoogle Scholar
  30. 30.
    Bilhim T, Pisco J, Pereira JA, Costa NV, Fernandes L, Campos Pinheiro L et al (2016) Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology 281:289–300CrossRefGoogle Scholar
  31. 31.
    Bagla S, Smirniotopoulos J, Orlando JC, Piechowiak R (2017) Robotic-assisted versus manual prostatic arterial embolization for benign  prostatic hyperplasia: a comparative analysis. Cardiovasc Intervent Radiol 40:360–365CrossRefGoogle Scholar

Copyright information

© Italian Society of Medical Radiology 2018

Authors and Affiliations

  • Hongtao Zhang
    • 1
    • 2
  • Yanguang Shen
    • 1
  • Jingjing Pan
    • 1
    • 3
  • Haiyi Wang
    • 1
  • Yan Zhong
    • 1
  • Yingwei Wang
    • 1
  • Huiyi Ye
    • 1
    Email author
  1. 1.Department of RadiologyChinese PLA General HospitalBeijingChina
  2. 2.Department of Radiology, 307 HospitalPLABeijingChina
  3. 3.Department of RadiologyGeneral Hospital of the PLA Rocket ForceBeijingChina

Personalised recommendations